Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
SHSE:688198's PEG Ratio is ranked better than 56.87% of 211
companies
in the Medical Devices & Instruments industry
Industry Median: 1.85
vs SHSE:688198: 1.55
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Beijing Balance Medical Technology Co (SHSE:688198) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Beijing Balance Medical Technology Co PEG Ratio Related Terms
Beijing Balance Medical Technology Co PEG Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Balance Medical Technology Co PEG Ratio Chart
SHSE:688198 vs ABT, SYK, MDT: PEG Ratio Comparison
For the Medical Devices subindustry, Beijing Balance Medical Technology Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beijing Balance Medical Technology Co PEG Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Beijing Balance Medical Technology Co's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Beijing Balance Medical Technology Co's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Beijing Balance Medical Technology Co (SHSE:688198) has a PEG Ratio of 1.55 as of Sep. 08, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Beijing Balance Medical Technology Co and its competitors. This is 66% below median its historical median of 4.53. Over the past decade, Beijing Balance Medical Technology Co's PEG Ratio has ranged from 1.50 to 15.84. According to the industry distribution chart, Beijing Balance Medical Technology Co ranks #91 out of 211 companies in the Medical Devices & Instruments industry, placing it in the top 43.1%.
Is Beijing Balance Medical Technology Co's PEG Ratio too high?
Beijing Balance Medical Technology Co's current PEG Ratio of 1.55 is 66% below median its 10-year median of 4.53. Over the past 10 years, this metric has ranged from a low of 1.50 to a high of 15.84. The Medical Devices & Instruments industry median PEG Ratio is 1.85. Beijing Balance Medical Technology Co's value of 1.55 is 16.2% below this industry median. Based on the distribution chart, Beijing Balance Medical Technology Co ranks #91 out of 211 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Beijing Balance Medical Technology Co has a GF Score™ of 86/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Beijing Balance Medical Technology Co's PEG Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Beijing Balance Medical Technology Co ranks #91 out of 211 companies for PEG Ratio. This puts Beijing Balance Medical Technology Co in the upper half of its industry. The industry median PEG Ratio is 1.85. Beijing Balance Medical Technology Co's value of 1.55 is 16.2% below this benchmark. Historically, Beijing Balance Medical Technology Co's own PEG Ratio has ranged from 1.50 to 15.84 over the past decade. While the company's 10-year median is 4.53 vs. the industry median of 1.85, Beijing Balance Medical Technology Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Devices & Instruments company?
The median PEG Ratio among Medical Devices & Instruments companies is 1.85, based on 211 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beijing Balance Medical Technology Co's current PEG Ratio of 1.55 is 16.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Beijing Balance Medical Technology Co and its competitors. For the Medical Devices & Instruments industry, the median PEG Ratio is 1.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beijing Balance Medical Technology Co's current PEG Ratio is 1.55, which is 66% below median its own 10-year median of 4.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Balance Medical Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Beijing Balance Medical Technology Co (SHSE:688198) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥168.04, compared to a current price of ¥70.26 — trading 58.2% below its estimated fair value. The current PEG Ratio is 1.55, which is 66% below median its 10-year median of 4.53 and 16.2% below the Medical Devices & Instruments industry median of 1.85. Beijing Balance Medical Technology Co's overall GF Score™ is 86/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Beijing Balance Medical Technology Co (SHSE:688198), the current PEG Ratio is 1.55 as of Sep. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beijing Balance Medical Technology Co (SHSE:688198) Overvalued in 2026?
Based on GuruFocus' analysis, Beijing Balance Medical Technology Co stock appears to be undervalued.
The current stock price of ¥70.26 is trading 58.2% below its estimated GF Value™ of ¥168.04.
GuruFocus considers Beijing Balance Medical Technology Co to be Significantly Undervalued.
Key valuation signals for SHSE:688198:
PEG Ratio: 1.55 (66% below median its 10-year median of 4.53)
GF Value™: ¥168.04 vs. price of ¥70.26 (58.2% below fair value)
Industry Position: 16.2% below the Medical Devices & Instruments median (#91 of 211)
No single metric tells the full story. See the SHSE:688198 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beijing Balance Medical Technology Co Ltd is engaged in the research and development and production of animal-derived implantable medical devices. The company's products are used in heart valve replacement and repair, congenital heart disease implant intervention and surgical soft tissue repair.
86GF Score
Get the complete analysis for SHSE:688198
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688198 has been successfully added to your 
